公司资料
eFFECTOR Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- EFTR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (-62.50%)
收盘价
最后更新: 2026年8月21日
—
市值
股价为何变动
Current closing-price context is not available for EFTR.
公司概览
业务概览
eFFECTOR Therapeutics was a biotechnology company focused on translational control and cancer drug development. Its story was centered on trying to create differentiated oncology medicines from a specific biologic mechanism.
所在地与行业分类
eFFECTOR was headquartered in the United States and listed on NASDAQ. It sat in development-stage oncology biotechnology.
商业模式特征
The company depended on clinical readouts, translational validation, and the ability to turn mechanism into therapeutic utility. Investors watched data quality, safety, and the path to a viable oncology franchise.
生物医药行业定位
eFFECTOR occupied a narrow oncology-biology niche within biotech. The stock was highly catalyst-sensitive because its value depended on a small number of clinical assets.
未来催化剂
- eFFECTOR is now mostly a legacy / closeout story, so the catalysts are any final strategic update rather than a live oncology milestone. The market is focused on residual value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。